Guardant health announces inducement grants under nasdaq listing rule 5635(c)(4)

Palo alto, calif.--(business wire)--guardant health, inc. (nasdaq: gh), a leading precision oncology company, today announced that on april 22, 2025, the compensation committee of guardant's board of directors approved the granting of restricted stock units (“rsus”) representing 157,466 shares of its common stock to 139 new non-executive employees and two non-qualified stock option awards to purchase 19,295 shares of its common stock to two new non-executive employees with a grant date of may 2.
NDAQ Ratings Summary
NDAQ Quant Ranking